Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « Fernando Kemta Lekpa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Fernando Garcia-Rodriguez < Fernando Kemta Lekpa < Fernando Martins  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000166 (2018) Fernando Kemta Lekpa [Cameroun] ; Xavier Chevalier [France]Refractory relapsing polychondritis: challenges and solutions
000618 (2012) Fernando Kemta Lekpa [France] ; Cécile Poulain [France] ; Daniel Wendling [France] ; Martin Soubrier [France] ; Michel De Bandt [France] ; Jean Marie Berthelot [France] ; Philippe Gaudin [France] ; Eric Toussirot [France] ; Philippe Goupille [France] ; Thao Pham [France] ; Jérémie Sellam [France] ; Rémy Bruckert [France] ; Muriel Paul [France] ; Valérie Farrenq [France] ; Pascal Claudepierre [France]Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study
000621 (2012) Fernando Kemta Lekpa [France] ; Virginia B. Kraus ; Xavier ChevalierBiologics in relapsing polychondritis: a literature review.
000651 (2012) Fernando Kemta Lekpa [France] ; Virginia B. Kraus [France] ; Xavier Chevalier [France]Biologics in Relapsing Polychondritis: A Literature Review

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Female
2Humans
2Male
2Treatment Outcome
2Tumor Necrosis Factor-alpha (antagonists & inhibitors)
1Adult
1Antibodies, Monoclonal (therapeutic use)
1Antibodies, Monoclonal, Humanized (administration & dosage)
1Antibodies, Monoclonal, Humanized (metabolism)
1Bibliographic review
1Chronic
1Drug Delivery Systems (methods)
1Follow-Up Studies
1Immunologic Factors (therapeutic use)
1Interleukin-6 (antagonists & inhibitors)
1Interleukin-6 (metabolism)
1Middle Aged
1Polychondritis, Relapsing (therapy)
1PubMed
1Relapsing polychondritis
1Retrospective Studies
1Review
1Rheumatology
1Spondylarthritis (drug therapy)
1Spondylarthritis (metabolism)
1Toxicity
1Treatment
1Tumor Necrosis Factor-alpha (metabolism)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Fernando Kemta Lekpa" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Fernando Kemta Lekpa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Fernando Kemta Lekpa
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021